B+
Overall grade
B
Financial quality
The sleeper story is labor cost discipline becoming structural advantage rather than cyclical recovery, with SWB dropping 260 bps while volumes surged 4.4%. The obvious headline is massive Q1 beat, but the real signal is management's refusal to raise guidance despite $100M+ outperformance. The binding constraint is management's confidence in policy environment, not operational capacity. Sutaria revealed the tell: 'We are not altering our business strategy because of healthcare policy uncertainty.' My view changes if they raise guidance next quarter, which would signal true visibility beyond policy noise.
The 30-second version
- Labor cost discipline is becoming structural, not cyclical
- Exchange volume surge proves sustainable despite redetermination fears
- USPI revenue per case hit 9.1% growth but management won't quantify the runway
What changed this quarter
| Metric | Prior | This quarter |
|---|---|---|
| Net Operating Revenues | $5.1B (Q4 2024) | $5.2B (Q1 2025) |
| Consolidated Adjusted EBITDA | $1.048B (Q4 2024) | $1.163B (Q1 2025) |
| Adjusted EBITDA Margin | 20.7% (Q4 2024) | 22.3% (Q1 2025) |
| USPI Adjusted EBITDA | $530M (Q4 implied) | $556M (Q1 2025) |
| USPI Same Facility Revenue Growth | 8.6% (Q4 2024) | 6.8% (Q1 2025) |
| USPI Revenue Per Case | Not disclosed (Q4) | +9.1% YoY (Q1 2025) |
| Hospital Same Store Admissions | 5% (Q4 2024) | 4.4% (Q1 2025) |
| Revenue Per Adjusted Admission | 0.6% (Q4 2024) | 2.8% (Q1 2025) |
Accountability tracked
6 new promises made4 narrative shifts flagged6 prior promises graded
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Subscribe to Call Sheet Daily →